Document text
Principal Investigator: BERNARDINO Francesco GHETTI
Organization: MAYO CLINIC JACKSONVILLE
Fiscal Year: 2024
Award: $3,080,100
Funding agency: National Institute on Aging
PROJECT SUMMARY/ABSTRACT
Development of cognitive problems at any age is devastating, but development of cognitive problems in
working-age people with dependents represents a major public health concern. Young-onset Alzheimer's
disease (YOAD) is defined as individuals who present before age 65 and lack mutations known to cause
Alzheimer's disease (AD) pathology. Neuropathology and neuroimaging studies demonstrate greater tau
accumulation in YOAD who often present with atypical, non-amnestic syndromes. Our preliminary data
demonstrates that tau accumulation occurs through progressive maturity levels in tangle-bearing neurons,
which disproportionately affects cortical more than limbic structures in YOAD. Moreover, we show younger age
onset is associated with greater tangle accumulation and neuronal loss in nucleus basalis of Meynert
(cholinergic hub) and locus coeruleus (noradrenergic hub) – two neuromodulatory hubs implicated in early
stage of disease. As stereotypic amyloid-β plaque patterns are robustly observed regardless of age, and
comorbid neuropathologies are less frequent in YOAD, this cohort is ideally suited for a targeted investigation
of selective vulnerabilities to tangle pathology in AD. Regional vulnerabilities to advanced tangle maturity levels
in corticolimbic structures and neuromodulatory hubs are hypothesized to underlie the syndromic heterogeneity
observed in YOAD. The overall goal of this grant is to uncover signatures of regional and cellular vulnerabilities
underlying syndromic heterogeneity in YOAD by investigating what modifies patterns of tangle accumulation
and microglial activation. Our preliminary data from single-cell RNA sequencing underscores the importance of
considering disease heterogeneity and the utility of quantitative neuropathology for validating gene expression
changes. This proposal seeks to shift current research in AD by focusing on younger-aged individuals and
demonstrating how regional variability can inform cellular biology even in the context of end-stage disease. To
accomplish our goals and facilitate stratification by atypical and typical (amnestic) clinical syndromes, the MPI
team has combined expertise and resources to amass one of the largest documented YOAD cohorts totaling
558 brains with available tissue for study. The goal of the grant is to test the following hypotheses: 1)
Modifiers of the neuropathologic patterns of tau pathology in YOAD brains differ between cases stratified
by atypical vs. typical (amnestic) clinical syndromes, 2) The most vulnerable neuronal populations to AD-tau
share a similar molecular signature across corticolimbic regions reflective of syndromic heterogeneity in
YOAD, and 3) Corticolimbic microglial activation patterns differ in the brains of YOAD cases stratified by
atypical vs. typical (amnestic) clinical syndrome. Completion of this project will identify specific cell populations
vulnerable to regional AD-tau pathology and identify modifiers of microglial activation patterns corresponding to
aggressive tau accumulation in YOAD.
Terms: <AD dementia><AD pathology><Affect><Age><Age of Onset><Alzheimer Type Dementia><Alzheimer disease dementia><Alzheimer risk factor><Alzheimer sclerosis><Alzheimer syndrome><Alzheimer's><Alzheimer's Disease><Alzheimer's brain><Alzheimer's disease brain><Alzheimer's disease pathology><Alzheimer's disease risk><Alzheimer's pathology><Alzheimers Dementia><Ammon Horn><Amyloid (Aβ) plaques><Amyloid Plaques><Area><Astrocytes><Astrocytus><Astroglia><Basal Nucleus of Meynert><Biological><Body Tissues><Brain><Brain Nervous System><Brain Trauma><Brain region><Cell Body><Cells><Cellular biology><Cessation of life><Clinical><Cognitive><Cornu Ammonis><Data><Death><Development><Disease><Disorder><Encephalon><Entorhinal Area><Environment><Evaluation><Expression Signature><Gene Expression><Gene Expression Profile><Genetic Alteration><Genetic Change><Genetic defect><Goals><Grant><Heterogeneity><Hippocampus><Hortega cell><Human><Individual><Inflammation><Investigation><LB disease><LB disorder><Late Onset Alzheimer Disease><Lesion><Lewy Body Disease><Lewy body disorder><Lewy disease><Lewy disorder><Locus Coeruleus><MT-bound tau><Maps><Measures><Mesulam Syndrome><Methods><Microglia><Modeling><Modern Man><Molecular><Molecular Fingerprinting><Molecular Profiling><Morphology><Mutation><Nature><Nerve Cells><Nerve Degeneration><Nerve Unit><Neural Cell><Neuritic Plaques><Neurobiology><Neurocyte><Neurofibrillary Tangles><Neuron Degeneration><Neurons><Nucleus Basalis of Meynert><Nucleus Pigmentosus Pontis><Pathology><Pathway interactions><Pattern><Persons><Population><Primary Progressive Aphasia><Primary Senile Degenerative Dementia><Public Health><Reporting><Research><Research Resources><Resources><Senile Plaques><Series><Severities><Stereotyping><Stratification><Structure><Symptoms><Syndrome><TAR DNA-binding protein 43><TDP-43><TDP43><Technology><Testing><Tissues><Traumatic Brain Injury><Vulnerable Populations><abnormally aggregated tau protein><aged group><aged groups><aged individual><aged individuals><aged people><aged person><aged persons><aged population><aged populations><ages><aging population><alzheimer risk><amyloid beta plaque><amyloid-b plaque><association cortex><association cortical><association cortices><astrocytic glia><aβ plaques><biologic><blue nucleus><cell biology><cell type><cholinergic><co-morbid><co-morbidity><cohort><comorbidity><cored plaque><cortico-basal syndrome><corticobasal syndrome><demographics><developmental><diffuse plaque><digital><digital pathology><disease heterogeneity><end stage disease><entorhinal cortex><experience><filamentous tau inclusion><gene expression pattern><gene expression signature><genome mutation><gitter cell><glial activation><glial cell activation><hippocampal><innovate><innovation><innovative><late onset alzheimer><locus ceruleus structure><mesoglia><microglial cell><microgliocyte><microtubule associated protein tau aggregation><microtubule associated protein tau deposit><microtubule bound tau><microtubule-bound tau><molecular profile><molecular signature><nerve cell death><nerve cell loss><neural control><neural degeneration><neural imaging><neural regulation><neuro-imaging><neurobiological><neurodegeneration><neurodegenerative><neurofibrillary degeneration><neurofibrillary lesion><neurofibrillary pathology><neuroimaging><neurological degeneration><neurological imaging><neuromodulation><neuromodulatory><neuron cell death><neuron cell loss><neuron death><neuron loss><neuron toxicity><neuronal><neuronal cell death><neuronal cell loss><neuronal death><neuronal degeneration><neuronal loss><neuronal patterning><neuronal toxicity><neuropathologic><neuropathological><neuropathology><neuroregulation><neurotoxicity><noradrenergic><nucleus basalis><paired helical filament of tau><pathway><perivascular glial cell><population aging><primary degenerative dementia><protein TDP-43><protein TDP43><protein expression><scRNA-seq><self-aggregate tau><senile dementia of the Alzheimer type><sex><single cell RNA-seq><single cell RNAseq><single cell expression profiling><single cell transcriptomic profiling><single-cell RNA sequencing><tangle><tau><tau PHF><tau Proteins><tau accumulation><tau aggregate><tau aggregation><tau factor><tau fibrillization><tau filament><tau neurofibrillary tangle><tau oligomer><tau paired helical filament><tau polymerization><tau-tau interaction><transcriptional profile><transcriptional signature><transcriptomics><traumatic brain damage><vulnerable group><vulnerable individual><vulnerable people><τ Proteins><τ aggregation>